Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

The Trump administration’s effort to impose new requirements on Novavax’s COVID-19 vaccine — the nation’s only traditional ...

says Siow Ming Lee, a medical oncologist at University College London, who is leading a clinical trial of an mRNA vaccine for lung cancer patients.

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: Regeneron Pharmaceuticals ( REGN 0.40%) and Moderna ( MRNA -0.79%).

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an ...

Experimental mRNA Cancer Vaccine Shows Potential for Advanced Stage Cancer Patients in Phase 1 Trial Sep. 13, 2024 — Interim data from the Phase I dose escalation part of the mRNA cancer ...

Banning mRNA technology in response to the many missteps of public health officials during the pandemic is a textbook example ...